Sleeve gastrectomy: 5-year outcomes of a single institution

Rawlins, Logan; Rawlins, Melissa P.; Brown, Carey C.; Schumacher, David

doi:10.1016/j.soard.2012.08.014

Cited by 161 publications

(59 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Independently of the technique used, many patients suffering from several co-morbidities such as hypertension, hyperlipidaemia, obstructive sleep apnoea, and gastroesophageal reflux recovered one year after the intervention, as previously detected in several works [21,22]. Furthermore, other risk factors associated with obesity, such as nephropathy [23], have been described to have a lower incidence in treated patients.…”

Section: Discussionmentioning

confidence: 73%

Remisja cukrzycy typu 2 po leczeniu bariatrycznym — porównanie różnych procedur

Fernández-Soto¹,

Martín-Leyva²,

González-Jiménez³

et al. 2017

Endokrynologia Polska

View full text Add to dashboard Cite

Introduction: We aimed to assess the mid-term type 2 diabetes mellitus recovery patterns in morbidly obese patients by comparing some relevant physiological parameters of patients of bariatric surgery between two types of surgical procedures: mixed (roux-en-Y gastric bypass and biliopancreatic diversion) and restrictive (sleeve gastrectomy). Material and methods: This is a prospective and observational study of co-morbid, type 2 diabetes mellitus evolution in 49 morbidly obese patients: 37 underwent mixed surgery procedures and 12 a restrictive surgery procedure. We recorded weight, height, body mass index, and glycaemic, lipid, and nutritional blood parameters, prior to procedure, as well as six and twelve months post-operatively. In addition, we tested for differences in patient recovery and investigated predictive factors in diabetes remission. Results: Both glycaemic and lipid profiles diminished significantly to healthy levels by 6 and 12 months post intervention. Type 2 diabetes mellitus showed remission in more than 80% of patients of both types of surgical procedures, with no difference between them. Baseline body mass index, glycated haemoglobin, and insulin intake, among others, were shown to be valuable predictors of diabetes remission one year after the intervention. Conclusions:The choice of the type of surgical procedure did not significantly affect the remission rate of type 2 diabetes mellitus in morbidly obese patients. (Endokrynol Pol 2017; 68 (1): 18-25)

show abstract

Section: Discussionmentioning

confidence: 73%

Remisja cukrzycy typu 2 po leczeniu bariatrycznym — porównanie różnych procedur

Fernández-Soto¹,

Martín-Leyva²,

González-Jiménez³

et al. 2017

Endokrynologia Polska

View full text Add to dashboard Cite

show abstract

“…[11,12,27] In these series, it was shown that T2DM remission rate was between 33 to 100% in mid-term follow-up. [19,27] Zachariah et al published long-term follow-up (60 months) outcomes including T2DM and arterial hypertension resolution rate, which were found 66% and 100%, respectively.…”

Section: Follow-up (Mo) %Ewlmentioning

confidence: 99%

“…The rate of 30 day postoperative mortality was reported as from 0% to 1.4% in twenty-three studies. [12,19,23,27] …”

Section: Complications and Operative Mortalitymentioning

confidence: 99%

“…Cottam et al [24] 2006 126 65.3 12 46 Hamoui et al [5] 2006 118 55 24 47.3 Lee et al [21] 2007 216 49 24 59 Nocca et al [20] 2007 163 45.9 24 61.5 Weiner et al [13] 2007 120 60.7 60 NR Yang O et al [8] 2008 138 50.6 24 46 Parikh et al [12] 2008 135 60.1 12 47.3 Felberbauer et al [18] 2008 126 48.1 19 NR Rubin et al [15] 2008 120 43.5 11 NR Fuks et al [24] 2009 135 48.8 12 49.4 Stroh et al [25] 2009 144 54.5 24 NR Bobowicz et al [26] 2011 112 44.6 22 46.6 Chopra et al [9] 2011 174 48.9 36 58.9 Rawlins et al [27] 2012 49 65 60 86 Catheline et al [28] 2013 45 49.1 60 50.7 Sieber et al [29] 2013 54 43 60 57.4 Zachariah et al [10] 2013 228 37.4 60 63.7 Bellows et al [30] 2014 63 51.8 17 47.2 Boza et al [22] 2014 161 34.9 60 62.9 the size of bougies is one of the important factors contributing to durable weight loss. [11,34] The other important point to the weight loss outcome after LSG might be the changes in the plasma levels of ghrelin.…”

Section: Follow-up (Mo) %Ewlmentioning

confidence: 99%

See 1 more Smart Citation

Laparoscopic sleeve gastrectomy: Technique and results

Coşkun¹,

Yardımcı²

2017

Laparosc Endosc Surg Sci

View full text Add to dashboard Cite

Laparoscopic sleeve gastrectomy (LSG) has gained popularity as stand-alone procedure. The objective of this study was to describe the surgical technique and evaluate the outcomes of LSG published in the literature. Twenty-six studies with 1 to 5 years of follow-up after LSG were analyzed. Of the 26 studies, 22 reported patient gender (n=2765) and 69.1% of the patients were women. Mean age of the patients was 41.05 years (22 studies; n=2483 patients). Mean preoperative body mass index in all twenty-four studies was 48.2 kg/m 2 (range: 37.2-65.3 kg/m 2 ). Overall mean percentage of excess weight loss after LSG reported in 17 studies was 57.7%. Postoperative complication rate ranged from 0% to 15.3%. Leak rate ranged from 0.7% to 5.1%, and mortality rate ranged from 0% to 1.4%. Eleven studies reported remission rate of postoperative co-morbidity data with follow-up period of 12 to 60 months. Existing data have identified that LSG is comparable to other accepted bariatric procedures, but long-term data is limited.

show abstract

“…SG is considered a restrictive procedure; however, it has been increasingly recognized to have metabolic effects similar to those observed after RYGB (21). A recent 5-year outcomes study has reported successful SG results, with an 86% average EWL (22). However, other studies have demonstrated more modest long-term weight loss results (especially in patients with BMI O50 kg/m 2 ), with many patients ultimately requiring revision surgery for inadequate weight loss or recidivism (23).…”

Section: Weight Lossmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery

Corcelles

Daigle

Schauer

2016

European Journal of Endocrinology

View full text Add to dashboard Cite

Obesity is associated with an increased risk of type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease, osteoarthritis, numerous cancers and increased mortality. It is estimated that at least 2.8 million adults die each year due to obesity-related cardiovascular disease. Increasing in parallel with the global obesity problem is metabolic syndrome, which has also reached epidemic levels. Numerous studies have demonstrated that bariatric surgery is associated with significant and durable weight loss with associated improvement of obesity-related comorbidities. This review aims to summarize the effects of bariatric surgery on the components of metabolic syndrome (hyperglycemia, hyperlipidemia and hypertension), weight loss, perioperative morbidity and mortality, and the long-term impact on cardiovascular risk and mortality.

show abstract

Sleeve gastrectomy: 5-year outcomes of a single institution

Cited by 161 publications

References 18 publications

Remisja cukrzycy typu 2 po leczeniu bariatrycznym — porównanie różnych procedur

Remisja cukrzycy typu 2 po leczeniu bariatrycznym — porównanie różnych procedur

Laparoscopic sleeve gastrectomy: Technique and results

MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery

Contact Info

Product

Resources

About